派格生物医药(杭州)股份有限公司于2026年4月8日发布了截至2026年3月31日的月度股份变动报告。报告显示，公司本月未有新增发行、购回或注销活动，股本结构保持稳定。
根据公告，截至报告期末，公司已发行的H股数量为284,300,339股，非上市股份数量为106,791,193股，公司注册股本总额为人民币391,091,532元，均与上月保持一致。报告同时指出，公司无股份期权、可换股票据或其他股份激励工具的新增或行使情况。
公告显示，公司确认符合香港联交所《上市规则》有关维持足够公众持股量的要求。上述信息由联席公司秘书黄一峰签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.